Dexmedetomidine in the neurointensive care unit

Discov Med. 2010 Jan;9(44):42-5.

Abstract

Dexmedetomidine is a new alpha-2 agonist with high specificity to alpha-2 receptors. The aim of this review is to present the most recent topics regarding the advantages in using dexmedetomidine in clinical anesthesia and intensive care, while discussing the controversial issue of its harmful effect on cerebral blood flow.

Publication types

  • Review

MeSH terms

  • Adrenergic alpha-Agonists / adverse effects
  • Adrenergic alpha-Agonists / pharmacology
  • Adrenergic alpha-Agonists / therapeutic use*
  • Anesthesia / methods
  • Cerebrovascular Circulation / drug effects
  • Critical Care*
  • Dexmedetomidine / adverse effects
  • Dexmedetomidine / pharmacology
  • Dexmedetomidine / therapeutic use*
  • Humans

Substances

  • Adrenergic alpha-Agonists
  • Dexmedetomidine